IN THE UNITED STATES DISTRICT COURT
FOR THE NORTHERN DISTRICT OF TEXAS
UNITED STATES OF AMERICA,
v.
F. HOFFMANN-LA ROCHE LTD
Defendant.
|
|
|
|
|
|
|
|
|
|
|
|
Criminal No. 3:99-CR-184-R
Filed: May 20, 1999
Violation: 15 U.S.C. § 1
|
INFORMATION
The United States of America, acting through its attorneys, charges:
I
DESCRIPTION OF THE OFFENSE
1. F. Hoffmann-La Roche Ltd ("the defendant"), a corporation organized and
existing under the laws of Switzerland, is made a defendant on the charge stated
below.
2. Beginning in part at least as early as January 1990 and continuing in part
until February 1999, the exact dates being unknown to the United States, the defendant
and co-conspirators entered into and participated in a combination and conspiracy to
suppress and eliminate competition by fixing the price and allocating the volume of
certain vitamins manufactured and sold in the United States and elsewhere, and to
allocate customers for vitamin premixes sold in the United States. The combination
and conspiracy engaged in by the defendant and its co-conspirators was in
unreasonable restraint of interstate and foreign trade and commerce in violation of
Section 1 of the Sherman Act (15 U.S.C. § 1).
3. The charged combination and conspiracy:
- consisted of a continuing agreement, understanding, and concert of
action among the defendant and co-conspirators regarding certain
vitamins manufactured by the corporate conspirators and sold by
them in the United States and elsewhere, the substantial terms of
which were to:
- fix, increase, and maintain prices and to coordinate price
increases for the sale of such vitamins in the United States
and elsewhere;
- allocate among the corporate conspirators the volume of
sales and market shares of such vitamins in the United
States and elsewhere; and,
- allocate among corporate conspirators all or part of certain
contracts to supply vitamin premixes to various customers
located throughout the United States and to refrain from
submitting bids, or to submit collusive, non-competitive and
rigged bids, therefor;
- involved a changing group of conspirators and affected, as set forth
below, a changing group of vitamins at various points in time during
the period covered by this Information, its scope adjusting over
time to the manufacturers producing certain vitamins and
participating in the combination and conspiracy; and,
- affected at least the following vitamins for the indicated time
periods during the combination and conspiracy charged in this
Information:
- vitamins A and E sold in the United States and elsewhere,
from January 1990 into February 1999;
- vitamin B2 (Riboflavin) sold in the United States and
elsewhere, from at least January 1991 into at least Fall
1995;
- vitamin B5 (CalPan) sold in the United States and
elsewhere, from January 1991 into at least December 1998;
- vitamin C sold in the United States and elsewhere, from
January 1991 into at least the late Fall 1995;
- beta carotene sold in the United States and elsewhere, from
January 1991 into at least December 1998; and,
- vitamin premixes sold to customers located throughout the
United States, from January 1991 into at least December
1997.
4. For the purpose of forming and carrying out the charged combination
and conspiracy, the defendant and co-conspirators did those things that
they combined and conspired to do including, among other things:
Vitamins
- participating in meetings and conversations in the United States
and elsewhere to discuss the prices and volumes of vitamins A and
E, vitamin B2, vitamin B5, vitamin C, and beta carotene sold in the
United States and elsewhere;
- agreeing, during such meetings and conversations regarding such
vitamins, to fix, increase, and maintain prices at certain levels in the
United States and elsewhere;
- agreeing, during such meetings and conversations regarding such
vitamins, to allocate among the corporate conspirators the
approximate volume of such vitamins to be sold by them in the
United States and elsewhere;
- exchanging sales and customer information for the purpose of
monitoring and enforcing adherence to the above-described
agreements;
- issuing price announcements and price quotations in accordance
with the above-described agreements;
- selling such vitamins at the agreed-upon prices and in accordance
with the agreed-upon sales volume allocations in the United States
and elsewhere;
Vitamin Premixes
- participating in meetings and conversations in the United States
and elsewhere to discuss the submission of prospective bids for
contracts to supply vitamin premixes to various customers located
throughout the United States;
- agreeing, during such meetings and conversations, which
corporate conspirator would be designated the low bidder for
particular contracts to supply vitamin premixes to various
customers located throughout the United States;
- agreeing, during such meetings and conversations, on the prices to
be submitted by the designated low bidders for particular contracts
to supply vitamin premixes to various customers throughout the
United States;
- refraining from bidding, or submitting intentionally high,
complementary and non-competitive bids, for particular contracts to
supply vitamin premixes to various customers throughout the
United States; and
- selling vitamin premixes to various customers throughout the
United States at rigged and non-competitive prices.
II
BACKGROUND
5. Vitamins are organic compounds required in the diet of humans and
animals for normal growth and maintenance of life. Vitamins are essential sources of
certain coenzymes necessary for metabolism, the biochemical processes that support
life. All known vitamins have been synthesized chemically, and various such
synthesized vitamins are manufactured and sold by the defendant and its corporate co-conspirators.
6. Vitamins are necessary for the normal and healthy growth and
development of both humans and animals. Large quantities of vitamins A and E,
vitamin B2, vitamin B5, vitamin C, and beta carotene are sold to customers in the human
food, pharmaceutical and animal feed industries. Vitamin premixes are a blend of
several vitamins and other products in either dry or spray-on applications. Formulated
and sold as additives, these vitamin premix applications are used to enrich human food
and animal feed products.
III
DEFENDANT AND CO-CONSPIRATORS
7. During the period covered by this Information, the defendant was a
corporation organized and existing under the laws of Switzerland, with its principal place
of business in Basel, Switzerland. The defendant is engaged in the manufacture and
sale of vitamins and vitamin premixes to the United States and elsewhere.
8. Various corporations and individuals not made defendants herein
participated as co-conspirators in the offense charged herein and performed acts and
made statements in furtherance thereof.
9. Wherever in this Information reference is made to any act, deed, or
transaction of a corporation, the allegation means that the corporation engaged in the
act, deed, or transaction by or through its officers, directors, agents, employees, or
representatives while they were actively engaged in the management, direction, control,
or transaction of its business or affairs.
IV
TRADE AND COMMERCE
10. During the period covered by this Information, the defendant and its
co-conspirators sold and distributed a substantial quantity of vitamins and vitamin
premixes subject to the charged conspiracy in a continuous and uninterrupted flow of
interstate and foreign trade and commerce to customers located in states or countries
other than the states or countries in which the vitamins and vitamin premixes were
produced.
11. During the period covered by this Information, the activities of the
defendant and co-conspirators that are the subject of this Information were within the
flow of, and substantially affected, interstate and foreign trade and commerce.
V
JURISDICTION AND VENUE
12. The combination and conspiracy charged in this Information was carried
out, in part, within the Northern District of Texas within the five years preceding the filing
of this Information.
ALL IN VIOLATION OF TITLE 15, UNITED STATES CODE, SECTION 1.
Dated:
|
_______________/s/________________
JOEL I. KLEIN
Assistant Attorney General
_______________/s/________________
GARY R. SPRATLING
Deputy Assistant Attorney General
_______________/s/________________
JAMES M. GRIFFIN
Director of Criminal Enforcement
Antitrust Division
U.S. Department of Justice
|
_______________/s/________________
ALAN A. PASON
Chief, Dallas Office
_______________/s/________________
GREGORY S. GLOFF
MITCHELL R. CHITWOOD
Attorneys, Antitrust Division
U.S. Department of Justice
Dallas Field Office
Thanksgiving Tower
1601 Elm Street, Suite 4950
Dallas, Texas 75201-4717
Tel.: (214) 880-9401
|
|